$266 Million is the total value of Sio Capital Management, LLC's 62 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 60.6% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ABC | Buy | AMERISOURCEBERGEN CORP | $25,938,000 | +101.3% | 183,334 | +120.2% | 9.74% | +128.6% |
| MSAC | MEDICUS SCIENCES ACQUISITION | $22,719,000 | 0.0% | 2,323,000 | 0.0% | 8.53% | +13.5% | |
| OGN | New | ORGANON & CO | $19,401,000 | – | 574,855 | +100.0% | 7.29% | – |
| CI | Sell | CIGNA CORP | $13,976,000 | -14.0% | 53,034 | -21.8% | 5.25% | -2.4% |
| INGN | Buy | INOGEN INC | $12,705,000 | -2.1% | 525,438 | +31.3% | 4.77% | +11.2% |
| BCYC | Buy | BICYCLE THERAPEUTICS PLCsponsored ads | $11,561,000 | +399.2% | 688,989 | +1205.2% | 4.34% | +466.8% |
| CNC | Buy | CENTENE CORP | $10,916,000 | +34.0% | 129,011 | +33.3% | 4.10% | +52.1% |
| HCA | New | HCA HEALTHCARE INC | $10,412,000 | – | 61,953 | +100.0% | 3.91% | – |
| UTHR | Sell | UNITED THERAPEUTICS CORP | $9,416,000 | -5.0% | 39,959 | -27.7% | 3.54% | +7.8% |
| BHC | Buy | BAUSCH HEALTH COMPANIES INCput | $8,717,000 | +3058.3% | 1,042,700 | +8517.4% | 3.27% | +3497.8% |
| NARI | Buy | INARI MEDICAL INC | $7,647,000 | +109.8% | 112,466 | +179.7% | 2.87% | +138.1% |
| BIIB | New | BIOGEN INC | $7,321,000 | – | 35,900 | +100.0% | 2.75% | – |
| MDT | New | MEDTRONIC PLC | $7,180,000 | – | 80,000 | +100.0% | 2.70% | – |
| New | SIGHT SCIENCES INC | $6,517,000 | – | 724,944 | +100.0% | 2.45% | – | |
| NTUS | Sell | NATUS MEDICAL INC | $6,258,000 | +24.3% | 190,956 | -0.3% | 2.35% | +41.2% |
| CAH | New | CARDINAL HEALTH INC | $6,223,000 | – | 119,061 | +100.0% | 2.34% | – |
| THC | New | TENET HEALTHCARE CORP | $5,519,000 | – | 105,000 | +100.0% | 2.07% | – |
| VNDA | Buy | VANDA PHARMACEUTICALS INC | $5,330,000 | +190.0% | 488,965 | +200.9% | 2.00% | +229.3% |
| BHVN | New | BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD | $5,100,000 | – | 35,000 | +100.0% | 1.92% | – |
| SKIN | New | THE BEAUTY HEALTH COMPANY | $4,659,000 | – | 362,294 | +100.0% | 1.75% | – |
| INBX | Buy | INHIBRX INC | $4,145,000 | +49.7% | 365,210 | +193.9% | 1.56% | +70.0% |
| UHS | New | UNIVERSAL HEALTH SERVICES INCcl b | $4,101,000 | – | 40,725 | +100.0% | 1.54% | – |
| HSKA | New | HESKA CORP | $3,739,000 | – | 39,566 | +100.0% | 1.40% | – |
| PNT | Buy | POINT BIOPHARMA GLOBAL INC | $3,436,000 | +14.2% | 504,545 | +33.6% | 1.29% | +29.6% |
| HZNP | New | HORIZON THERAPEUTICS PUB L | $3,190,000 | – | 40,000 | +100.0% | 1.20% | – |
| New | MODULAR MEDICAL INC | $2,975,000 | – | 574,352 | +100.0% | 1.12% | – | |
| VKTX | VIKING THERAPEUTICS INC | $2,890,000 | -3.6% | 999,829 | 0.0% | 1.08% | +9.4% | |
| RXDX | New | PROMETHEUS BIOSCIENCES INCput | $2,868,000 | – | 101,600 | +100.0% | 1.08% | – |
| EUCRU | EUCRATES BIOMEDICAL ACQUISITION CORP.unit 10/23/2027 | $2,492,000 | +1.6% | 248,674 | 0.0% | 0.94% | +15.4% | |
| HSAQ | HEALTH SCIENCES ACQUISITIONS CORP 2 | $2,490,000 | +0.5% | 250,000 | 0.0% | 0.94% | +14.0% | |
| AGLE | Buy | AEGLEA BIO THERAPEUTICS INC | $2,358,000 | +17.7% | 4,668,536 | +435.9% | 0.89% | +33.6% |
| AFMD | Buy | AFFIMED NV | $2,274,000 | -19.2% | 821,065 | +27.6% | 0.85% | -8.3% |
| MRUS | Sell | MERUS NV | $1,991,000 | -16.3% | 87,953 | -2.3% | 0.75% | -5.0% |
| CBAY | Sell | CYMABAY THERAPEUTICS INC | $1,639,000 | -6.3% | 555,610 | -1.2% | 0.62% | +6.4% |
| DTIL | New | PRECISION BIOSCIENCES INC | $1,614,000 | – | 1,008,993 | +100.0% | 0.61% | – |
| MBRX | Sell | MOLECULIN BIOTECH INC | $1,503,000 | -18.8% | 1,036,853 | -0.4% | 0.56% | -7.8% |
| RENOVACOR INC | $1,492,000 | -52.2% | 735,908 | 0.0% | 0.56% | -45.7% | ||
| SVRA | Buy | SAVARA INC | $1,302,000 | +38.8% | 856,428 | +19.6% | 0.49% | +57.7% |
| ANIP | ANI PHARMACEUTICALS INC | $1,187,000 | +5.6% | 40,000 | 0.0% | 0.45% | +19.9% | |
| ALBO | Sell | ALBIREO PHARMA INC | $1,163,000 | -73.0% | 58,556 | -59.5% | 0.44% | -69.4% |
| Buy | TYRA BIOSCIENCES INC | $1,088,000 | -8.4% | 152,159 | +37.0% | 0.41% | +4.1% | |
| PARDES BIOSCIENCES INC | $969,000 | -57.5% | 315,564 | 0.0% | 0.36% | -51.7% | ||
| NBSE | NEUBASE THERAPEUTICS INC | $952,000 | -44.1% | 906,445 | 0.0% | 0.36% | -36.5% | |
| ISOPLEXIS CORP | $879,000 | -37.0% | 407,102 | 0.0% | 0.33% | -28.6% | ||
| ISEE | New | IVERIC BIO INCput | $831,000 | – | 86,400 | +100.0% | 0.31% | – |
| FUSN | Buy | FUSION PHARMACEUTICALS INC | $649,000 | -67.8% | 260,448 | +0.3% | 0.24% | -63.5% |
| ASLN | ASLAN PHARMACEUTICALS LTDads | $629,000 | -45.0% | 1,270,758 | 0.0% | 0.24% | -37.6% | |
| NXTC | NEXTCURE INC | $611,000 | -3.3% | 130,000 | 0.0% | 0.23% | +9.6% | |
| CNTB | CONNECT BIOPHARMA HOLDINGS LTDads | $520,000 | -71.2% | 597,678 | 0.0% | 0.20% | -67.3% | |
| ELEV | ELEVATION ONCOLOGY INC | $504,000 | -44.4% | 359,731 | 0.0% | 0.19% | -37.0% | |
| XENE | Sell | XENON PHARMACEUTICALS INC | $498,000 | -84.6% | 16,368 | -84.5% | 0.19% | -82.5% |
| CYCC | Buy | CYCLACEL PHARMACEUTICALS INC | $491,000 | -61.9% | 454,355 | +7.5% | 0.18% | -56.8% |
| ARDX | New | ARDELYX INC | $408,000 | – | 692,357 | +100.0% | 0.15% | – |
| XFOR | X4 PHARMACEUTICALS INC | $267,000 | -44.9% | 276,909 | 0.0% | 0.10% | -37.5% | |
| NYXOAH SA | $148,000 | -51.9% | 16,110 | 0.0% | 0.06% | -45.1% | ||
| VINC | VINCERX PHARMA INC | $135,000 | -66.9% | 102,049 | 0.0% | 0.05% | -62.2% | |
| CMAX | CAREMAX INC | $112,000 | -51.3% | 30,741 | 0.0% | 0.04% | -44.7% | |
| BHC | New | BAUSCH HEALTH COMPANIES INC | $56,000 | – | 6,700 | +100.0% | 0.02% | – |
| HUMACYTE INC*w exp 09/21/202 | $45,000 | -53.6% | 49,998 | 0.0% | 0.02% | -46.9% | ||
| NLTX | NEOLEUKIN THERAPEUTICS INC | $39,000 | -45.8% | 38,312 | 0.0% | 0.02% | -37.5% | |
| RENOVACOR INC*w exp 99/99/999 | $34,000 | -79.8% | 400,000 | 0.0% | 0.01% | -76.8% | ||
| CMAXW | CAREMAX INC*w exp 06/08/2026 | $9,000 | -55.0% | 12,808 | 0.0% | 0.00% | -57.1% | |
| LOGC | Exit | LOGICBIO THERAPEUTICS INC | $0 | – | -182,630 | -100.0% | -0.04% | – |
| KZR | Exit | KEZAR LIFE SCIENCES INC | $0 | – | -9,168 | -100.0% | -0.05% | – |
| KOD | Exit | KODIAK SCIENCES INCcall | $0 | – | -30,600 | -100.0% | -0.08% | – |
| AYLA | Exit | AYALA PHARMACEUTICALS INC | $0 | – | -60,220 | -100.0% | -0.08% | – |
| RDUS | Exit | RADIUS HEALTH INC | $0 | – | -44,400 | -100.0% | -0.13% | – |
| AVAH | Exit | AVEANNA HEALTHCARE HOLDINGS INC | $0 | – | -131,812 | -100.0% | -0.15% | – |
| SYRS | Exit | SYROS PHARMACEUTICALS INC | $0 | – | -902,907 | -100.0% | -0.36% | – |
| SRRA | Exit | SIERRA ONCOLOGY INC | $0 | – | -48,768 | -100.0% | -0.52% | – |
| MIRM | Exit | MIRUM PHARMACEUTICALS INC | $0 | – | -161,285 | -100.0% | -1.18% | – |
| NKTR | Exit | NEKTAR THERAPEUTICSput | $0 | – | -693,700 | -100.0% | -1.24% | – |
| CRIS | Exit | CURIS INC | $0 | – | -1,915,460 | -100.0% | -1.51% | – |
| MEDP | Exit | MEDPACE HOLDINGS INC | $0 | – | -28,400 | -100.0% | -1.54% | – |
| VAPO | Exit | VAPOTHERM INC | $0 | – | -353,006 | -100.0% | -1.62% | – |
| IONS | Exit | IONIS PHARMACEUTICALS INC | $0 | – | -175,568 | -100.0% | -2.15% | – |
| VREX | Exit | VAREX IMAGING CORP | $0 | – | -315,486 | -100.0% | -2.22% | – |
| GLPG | Exit | GALAPAGOS NVspon adr | $0 | – | -146,696 | -100.0% | -3.01% | – |
| MCK | Exit | MCKESSON CORP | $0 | – | -34,501 | -100.0% | -3.49% | – |
| LH | Exit | LABORATORY CORPORATION OF AMERICA HOLDINGS | $0 | – | -49,328 | -100.0% | -4.30% | – |
| VRTX | Exit | VERTEX PHARMACEUTICALS INCcall | $0 | – | -58,500 | -100.0% | -5.05% | – |
| SNY | Exit | SANOFI SAsponsored adr | $0 | – | -300,000 | -100.0% | -5.10% | – |
| MRK | Exit | MERCK & CO INC | $0 | – | -195,160 | -100.0% | -5.30% | – |
| VRTX | Exit | VERTEX PHARMACEUTICALS INCput | $0 | – | -133,000 | -100.0% | -11.48% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-08-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| VIKING THERAPEUTICS INC | 24 | Q3 2023 | 3.4% |
| UNITED THERAPEUTICS ORD | 23 | Q3 2023 | 8.3% |
| CARDINAL HEALTH ORD | 20 | Q2 2022 | 7.2% |
| SANOFI SA | 19 | Q3 2022 | 9.8% |
| MEDTRONIC PLC | 18 | Q3 2023 | 5.2% |
| CATALYST BIOSCIENCES INC | 18 | Q3 2021 | 17.8% |
| PFENEX ORD | 18 | Q4 2019 | 5.9% |
| AEGLEA BIOTHERAPEUTICS INC | 18 | Q1 2023 | 1.1% |
| HCA HEALTHCARE INC | 17 | Q2 2022 | 5.5% |
| MCKESSON ORD | 17 | Q1 2022 | 6.0% |
View Sio Capital Management, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Modular Medical, Inc. | February 13, 2023 | 1,091,479 | 10.0% |
| Cellectar Biosciences, Inc. | February 10, 2022 | ? | ? |
| CURIS INC | February 10, 2022 | 3,866,645 | 4.2% |
| Salarius Pharmaceuticals, Inc. | February 10, 2022 | 1,354,291 | 3.0% |
| Larimar Therapeutics, Inc. | February 16, 2021 | 188,661 | 1.2% |
| ACHIEVE LIFE SCIENCES, INC. | February 14, 2020 | ? | ? |
| Bionano Genomics, Inc | February 14, 2020 | 1,210,821 | 4.6% |
| Brickell Biotech, Inc. | February 14, 2020 | ? | ? |
| Trillium Therapeutics Inc. | February 14, 2020 | 2,751,186 | 9.8% |
| ZAFGEN, INC. | February 14, 2020 | 2,283,164 | 6.1% |
View Sio Capital Management, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G/A | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| 13F-HR | 2024-02-13 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-12 |
| 13F-HR | 2023-02-13 |
| SC 13G | 2023-02-13 |
| 13F-HR | 2022-11-14 |
View Sio Capital Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.